Individualized Ofatumumab versus Fixed Low-Dose Rituximab in MuSK-Antibody-Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
- DOI
- 10.1016/j.clineuro.2026.109660
- Published
- 2026 Oct 4
- Container
- Clinical neurology and neurosurgery
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clineuro.2026.109660,
title = {Individualized Ofatumumab versus Fixed Low-Dose Rituximab in MuSK-Antibody-Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study.},
author = {Zhou Q and Zhong Y and Yin W and Jiang F and Zeng Q and Shi G and Ouyang Y and He T and Dong X and Wen Z and Cai H and Xiang W and Wang L and Li K and Yang H},
year = {2026},
journal = {Clinical neurology and neurosurgery},
doi = {10.1016/j.clineuro.2026.109660},
url = {https://doi.org/10.1016/j.clineuro.2026.109660}
}RIS
TY - JOUR TI - Individualized Ofatumumab versus Fixed Low-Dose Rituximab in MuSK-Antibody-Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study. AU - Zhou Q AU - Zhong Y AU - Yin W AU - Jiang F AU - Zeng Q AU - Shi G AU - Ouyang Y AU - He T AU - Dong X AU - Wen Z AU - Cai H AU - Xiang W AU - Wang L AU - Li K AU - Yang H PY - 2026 JO - Clinical neurology and neurosurgery DO - 10.1016/j.clineuro.2026.109660 UR - https://doi.org/10.1016/j.clineuro.2026.109660 ER -
APA
Q, Z., Y, Z., W, Y., F, J., Q, Z., G, S., Y, O., T, H., X, D., Z, W., H, C., W, X., L, W., K, L., & H, Y. (2026). Individualized Ofatumumab versus Fixed Low-Dose Rituximab in MuSK-Antibody-Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study.. Clinical neurology and neurosurgery. https://doi.org/10.1016/j.clineuro.2026.109660
Source records
- pubmed · retrieved 2026-11-10T16:45:56.300Z